BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 35859895)

  • 1. Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders.
    Priyanka ; Seth P
    Front Cell Dev Biol; 2022; 10():903031. PubMed ID: 35859895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis.
    Priyanka ; Wadhwa R; Chaudhuri R; Nag TC; Seth P
    J Neuroinflammation; 2020 Sep; 17(1):276. PubMed ID: 32951595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Wakhloo D; Oberhauser J; Madira A; Mahajani S
    Neural Regen Res; 2022 Dec; 17(12):2606-2614. PubMed ID: 35662189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.
    Cook TJ; Hoekstra JG; Eaton DL; Zhang J
    Brain Pathol; 2016 Jan; 26(1):75-81. PubMed ID: 26095919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortalin inhibition in experimental Parkinson's disease.
    Chiasserini D; Tozzi A; de Iure A; Tantucci M; Susta F; Orvietani PL; Koya K; Binaglia L; Calabresi P
    Mov Disord; 2011 Aug; 26(9):1639-47. PubMed ID: 21542017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
    Burbulla LF; Schelling C; Kato H; Rapaport D; Woitalla D; Schiesling C; Schulte C; Sharma M; Illig T; Bauer P; Jung S; Nordheim A; Schöls L; Riess O; Krüger R
    Hum Mol Genet; 2010 Nov; 19(22):4437-52. PubMed ID: 20817635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells.
    Qu M; Zhou Z; Xu S; Chen C; Yu Z; Wang D
    Brain Res; 2011 Jan; 1368():336-45. PubMed ID: 20974113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.
    Zhu JY; Vereshchagina N; Sreekumar V; Burbulla LF; Costa AC; Daub KJ; Woitalla D; Martins LM; Krüger R; Rasse TM
    PLoS One; 2013; 8(12):e83714. PubMed ID: 24386261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA9/Mortalin mediates axo-protection and modulates mitochondrial dynamics in neurons.
    Ferré CA; Thouard A; Bétourné A; Le Dorze AL; Belenguer P; Miquel MC; Peyrin JM; Gonzalez-Dunia D; Szelechowski M
    Sci Rep; 2021 Sep; 11(1):17705. PubMed ID: 34489498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From proliferative to neurological role of an hsp70 stress chaperone, mortalin.
    Deocaris CC; Kaul SC; Wadhwa R
    Biogerontology; 2008 Dec; 9(6):391-403. PubMed ID: 18770009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortalin - a multipotent chaperone regulating cellular processes ranging from viral infection to neurodegeneration.
    Flachbartová Z; Kovacech B
    Acta Virol; 2013; 57(1):3-15. PubMed ID: 23530819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure.
    Panes JD; Wendt A; Ramirez-Molina O; Castro PA; Fuentealba J
    Neural Regen Res; 2022 Feb; 17(2):237-245. PubMed ID: 34269182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mortalin in cellular senescence from the perspective of its mitochondrial import, chaperone, and oxidative stress management functions.
    Yaguchi T; Aida S; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2007 Apr; 1100():306-11. PubMed ID: 17460192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease.
    Olagunju AS; Ahammad F; Alagbe AA; Otenaike TA; Teibo JO; Mohammad F; Alsaiari AA; Omotoso O; Talukder MEK
    Heliyon; 2023 Mar; 9(3):e14387. PubMed ID: 36942213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
    Canet G; Dias C; Gabelle A; Simonin Y; Gosselet F; Marchi N; Makinson A; Tuaillon E; Van de Perre P; Givalois L; Salinas S
    Front Cell Neurosci; 2018; 12():307. PubMed ID: 30254568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.